Evidence map›Paper›PMID 29459767›Full record

ArticleCell death and differentiation2018

Mcl-1 and Bcl-x

Colin Hockings, Amber E Alsop, Stephanie C Fennell, Erinna F Lee, W Douglas Fairlie, Grant Dewson, Ruth M Kluck

Abstract read
In one paragraph

Article in Cell death and differentiation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Apoptotic mitochondrial poration by a growing list of pore-forming BCL-2 family proteins.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Mcl-1 and Bok transmembrane domains: Unexpected players in the modulation of apoptosis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Colin HockingsThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Amber E AlsopThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.ORCID http://orcid.org/0000-0001-7894-7294
Stephanie C FennellThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Erinna F LeeOlivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
W Douglas FairlieOlivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia.
Grant DewsonThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Ruth M KluckThe Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. kluck@wehi.edu.au.ORCID http://orcid.org/0000-0002-7101-1925

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prosurvival Bcl-2 family proteins Mcl-1 and Bcl-x

Indexed as

Animalsbcl-2 Homologous Antagonist-Killer Proteinbcl-X ProteinBiphenyl CompoundsMiceMice, KnockoutMyeloid Cell Leukemia Sequence 1 ProteinNitrophenolsPiperazinesSulfonamidesABT-737Bak1 protein, mousebcl-2 Homologous Antagonist-Killer ProteinBcl2l1 protein, mousebcl-X ProteinBiphenyl CompoundsMcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 ProteinNitrophenolsPiperazinesSulfonamides

Identifiers

PMID29459767
PMCPMC5864222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.